Home | Contact Us | Print Page | Your Cart | Sign In
International Guidelines

About the Guidelines

Goal: The goal of this international collaboration is to develop evidence-based recommendations for the prevention and treatment of pressure injuries that can be used by health professionals throughout the world.

 

Editions: The first edition of the guideline (2009) was developed as a four year collaboration between the National Pressure Ulcer Advisory Panel (NPUAP, now NPIAP) and the European Pressure Ulcer Advisory Panel (EPUAP). In the second edition of the guideline (2014), the Pan Pacific Pressure Injury Alliance (PPPIA) joined the NPUAP and EPUAP. The third edition of the guideline was released in November 2019. The fourth edition is being developed as a “living guideline” with ongoing additions and updates based on the latest research. 

The Online PI Guideline site was launched on February 27, 2025. To review current chapters (and monitor ongoing updates) see https://internationalguideline.com/the-international-guideline.

 

Methodology: For each edition of the guideline, an explicit scientific methodology was used to identify and critically appraise all available research. The methodology for each edition was published in advance. Drafts of the recommendations and supporting evidence were made available to invited stakeholders (individuals and organizations) around the world. The final guidelines were based on available research and the accumulated wisdom of the NPIAP, EPUAP, PPPIA, Associate Organizations, expert panels and international stakeholders.

In the 2nd edition of the guideline, a consensus voting process (GRADE) was used to assign a strength to each recommendation. The strength of recommendation identifies the importance of the recommendation statement based on potential to improve patient outcomes. It provides an indication to the health professional of the confidence one can have that the recommendation will do more good than harm, after careful consideration of multiple factors (certainty of evidence, desirable and undesirable effects, balance of effects, resources required, cost effectiveness, equity, acceptability and feasibility). For the fourth edition, the full GRADE process was implemented, providing a more rigorous analysis of the research while still providing clinically relevant implementation considerations and good practice statements for a variety of populations. 

 

Dissemination and Uptake: Each edition has been translated into multiple languages with over 200,000 copies distributed worldwide. Each edition has exceeded thresholds for “highly cited articles in clinical medicine” (El Genedy-Kalyoncu and Kottner, 2024).

 

Additional Information about the Four Editions

Visit the International Guideline Website (https://internationalguideline.com) for:
Archived Documents:

  • Clinical Practice Guideline: free digital copies of the 1st, 2nd and 3rd editions.
  • Quick Reference Guide: free digital copies of the 1st, 2nd and 3rd editions.
  • Note: A limited number of hard copies of the 2nd and 3rd editions are available for sale. (Contact the international guideline website administrator if interested)
  • Data Extraction Tables for the 1st, 2nd, and 3rd editions.
  • Evidence to Decision Frameworks for the 3rd edition.
 

New and Ongoing Updates from the 4th edition - Living Guideline 

Launched on February 27, 2025. See https://internationalguideline.com/the-international-guideline for the online Living Guideline containing:

  • Current Quick Reference Guide. Note: For chapters not yet completed, use the recommendations from the 3rd edition.
  • Acknowledgements of Guideline Contributors
  • Methodology Chapter
  • Definition and Etiology Chapter
  • Newly Approved Chapters:
    • Recommended chapter citation
    • Free, downloadable chapter in PDF Format
    • Introduction
    • Clinical questions that result in:
      • Recommendations
      • Good Practice Statements
      • Implementation Considerations (general and population-specific)
    • Supporting information (brief description of supporting information and available evidence)
    • Links to resources to support implementation (e.g., assessment tools, evidence-based protocols).
    • Reference Lists
    • Recommendations with evidence summary and links documenting:
      • Certainty of evidence determinations
      • Full Evidence to Decision Frameworks
      • Summary of Meta-analysis (when available)
      • Data Extraction Tables
Moving Forward: How is NPIAP supporting guideline implementation?
 

Contact Us

Connect With Us